137 related articles for article (PubMed ID: 19562346)
1. The value of an artificial neural network in the decision-making for prostate biopsies.
Meijer RP; Gemen EF; van Onna IE; van der Linden JC; Beerlage HP; Kusters GC
World J Urol; 2009 Oct; 27(5):593-8. PubMed ID: 19562346
[TBL] [Abstract][Full Text] [Related]
2. An artificial neural network to predict the outcome of repeat prostate biopsies.
Remzi M; Anagnostou T; Ravery V; Zlotta A; Stephan C; Marberger M; Djavan B
Urology; 2003 Sep; 62(3):456-60. PubMed ID: 12946746
[TBL] [Abstract][Full Text] [Related]
3. Internal validation of an artificial neural network for prostate biopsy outcome.
Stephan C; Cammann H; Bender M; Miller K; Lein M; Jung K; Meyer HA
Int J Urol; 2010 Jan; 17(1):62-8. PubMed ID: 19925616
[TBL] [Abstract][Full Text] [Related]
4. Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsies.
Stephan C; Cammann H; Semjonow A; Diamandis EP; Wymenga LF; Lein M; Sinha P; Loening SA; Jung K
Clin Chem; 2002 Aug; 48(8):1279-87. PubMed ID: 12142385
[TBL] [Abstract][Full Text] [Related]
5. Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routine.
Ecke TH; Bartel P; Hallmann S; Koch S; Ruttloff J; Cammann H; Lein M; Schrader M; Miller K; Stephan C
Urol Oncol; 2012; 30(2):139-44. PubMed ID: 20363164
[TBL] [Abstract][Full Text] [Related]
6. An artificial neural network for five different assay systems of prostate-specific antigen in prostate cancer diagnostics.
Stephan C; Cammann H; Meyer HA; Müller C; Deger S; Lein M; Jung K
BJU Int; 2008 Sep; 102(7):799-805. PubMed ID: 18522632
[TBL] [Abstract][Full Text] [Related]
7. A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.
Stephan C; Kahrs AM; Cammann H; Lein M; Schrader M; Deger S; Miller K; Jung K
Prostate; 2009 Feb; 69(2):198-207. PubMed ID: 18942119
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
9. A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
Auprich M; Augustin H; Budäus L; Kluth L; Mannweiler S; Shariat SF; Fisch M; Graefen M; Pummer K; Chun FK
BJU Int; 2012 Jun; 109(11):1627-35. PubMed ID: 21939492
[TBL] [Abstract][Full Text] [Related]
10. Benign prostatic hyperplasia-associated free prostate-specific antigen improves detection of prostate cancer in an artificial neural network.
Stephan C; Cammann H; Deger S; Schrader M; Meyer HA; Miller K; Lein M; Jung K
Urology; 2009 Oct; 74(4):873-7. PubMed ID: 19476981
[TBL] [Abstract][Full Text] [Related]
11. Pre-operative prediction of advanced prostatic cancer using clinical decision support systems: accuracy comparison between support vector machine and artificial neural network.
Kim SY; Moon SK; Jung DC; Hwang SI; Sung CK; Cho JY; Kim SH; Lee J; Lee HJ
Korean J Radiol; 2011; 12(5):588-94. PubMed ID: 21927560
[TBL] [Abstract][Full Text] [Related]
12. Novel artificial neural network for early detection of prostate cancer.
Djavan B; Remzi M; Zlotta A; Seitz C; Snow P; Marberger M
J Clin Oncol; 2002 Feb; 20(4):921-9. PubMed ID: 11844812
[TBL] [Abstract][Full Text] [Related]
13. External validation of an artificial neural network and two nomograms for prostate cancer detection.
Ecke TH; Hallmann S; Koch S; Ruttloff J; Cammann H; Gerullis H; Miller K; Stephan C
ISRN Urol; 2012; 2012():643181. PubMed ID: 22830050
[TBL] [Abstract][Full Text] [Related]
14. Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial.
Djavan B; Remzi M; Zlotta AR; Ravery V; Hammerer P; Reissigl A; Dobronski P; Kaisary A; Marberger M
Urology; 2002 Oct; 60(4 Suppl 1):4-9. PubMed ID: 12384156
[TBL] [Abstract][Full Text] [Related]
15. Artificial neural network (ANN) velocity better identifies benign prostatic hyperplasia but not prostate cancer compared with PSA velocity.
Stephan C; Büker N; Cammann H; Meyer HA; Lein M; Jung K
BMC Urol; 2008 Sep; 8():10. PubMed ID: 18764937
[TBL] [Abstract][Full Text] [Related]
16. Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?
Xu N; Wu YP; Chen DN; Ke ZB; Cai H; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY
J Cancer Res Clin Oncol; 2018 May; 144(5):987-995. PubMed ID: 29504080
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection.
Stephan C; Jung K; Soosaipillai A; Yousef GM; Cammann H; Meyer H; Xu C; Diamandis EP
BJU Int; 2005 Sep; 96(4):521-7. PubMed ID: 16104903
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of
Zhang J; Shao S; Wu P; Liu D; Yang B; Han D; Li Y; Lin X; Song W; Cao M; Zhang J; Kang F; Qin W; Wang J
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):908-920. PubMed ID: 30635755
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
[TBL] [Abstract][Full Text] [Related]
20. A (-5, -7) proPSA based artificial neural network to detect prostate cancer.
Stephan C; Meyer HA; Kwiatkowski M; Recker F; Cammann H; Loening SA; Jung K; Lein M
Eur Urol; 2006 Nov; 50(5):1014-20. PubMed ID: 16697520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
